— Ticker · NYQ —

RVTY · Revvity, Inc.

Healthcare · Diagnostics & Research

Revvity, Inc.

NYQ · Healthcare / Diagnostics & Research
All sectors →
RVTY
$135.04
▲ +3.37%
7-day move
day$128.90 → $135.3452-wk$81.22 → $135.34avg vol1.6M / 3Mcap$15.1B
Plate I.

The Past Year, in One Line

$130$140$150202120222023202420252026$135.04RVTY
The Valuation
P/E (forward)22.9
P/E (trailing)64.9
EPS (forward)$5.89
EPS (trailing)$2.08
PEG0.73
Dividend22.00%
The Risk
Beta1.09
Short % float8.47%
Float102.5M
Shares out111.6M
Avg vol (3M)1.6M
52w range$81.22 → $135.34
The Analyst Tape
strong buybuyholdunderperformsell
$126.12
avg 12-mo target
-6.6%
vs. last · 17 analysts
At a Glance
$15.1B
market cap (USD)
exchangeNYQ
sectorHealthcare
industryDiagnostics & Research
market cap$15.1B
websiterevvity.com

The Briefs

live, polled every 60 seconds · Alpaca / Benzinga
No recent headlines for RVTY in the last 7 days.

Word on the Street

StockTwits public feed · self-tagged bull/bear
No recent StockTwits posts for RVTY.

Indicators That Mention RVTY

8 of our 658 catalog map to RVTY
SP-1251
AbbVie
Pharma mega-cap. Production tell via epa_abbv_waste.
49%
49%
49%
49%
↓52%
48%
●Still works on fresh data
r=-0.10
SP-3079
XLV Healthcare ETF
Healthcare SPDR — pharma + biotech + insurers + devices. Broader than UNH alone.
49%
49%
50%
49%
50%
51%
●Still works on fresh data
r=-0.03
SP-1365
Pfizer
Big pharma. Vaccine + small-molecule production via epa_pfe_waste.
49%
49%
50%
49%
49%
49%
●Still works on fresh data
r=-0.02
SP-1458
UnitedHealth Group
Biggest US health insurer. Pricing power = consumer cost forecast.
49%
49%
49%
49%
50%
51%
●Still works on fresh data
r=-0.04
SP-3601
ABBV TRI Chemical Releases
Annual chemical releases from AbbVie US plants. Pharma batch chemistry.
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
SP-3174
AbbVie Hazardous Waste Tonnage
Monthly hazardous waste from AbbVie US plants. Drug batch chemistry, mixed-clean signal.
50%
50%
50%
50%
50%
50%
○Not yet retested on fresh data
r=0.00
SP-3646
LLY TRI Chemical Releases
Annual chemical releases from Eli Lilly US plants. Pharma production (incl. GLP-1).
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
SP-3667
MRK TRI Chemical Releases
Annual chemical releases from Merck US plants. Pharma + vaccine production.
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
Standard Poorly Disclaimer
We tested 658 indicators against six horizons. By chance alone, ~197 of these correlations should look "significant." Walk-forward out-of-sample is the only thing we trust.

Other Players in the Pipeline

Healthcare · by market cap · 7-day move
Metadata last refreshed 2026-09-15T13:59:52.634452+00:00 via yfinance. Price figures are end-of-day; intraday quotes are not surfaced on the free tier. We don't provide investment advice — see methodology for what we do and don't claim.

— Voices on RVTY —commentarylive

Curated commentary (Kobeissi, Doomberg, Lyn Alden, QuoteTheRaven, Pomp, ZeroHedge) mentioning RVTY. Opinion, not wire.
No recent commentary mentioning RVTY in the last 7 days.
Analyst · previewYou're seeing the public read on RVTY. Analyst unlocks every pundit call on RVTY with open P&L + alerts when a new position opens + the full related-indicator firing history. Trader adds intraday quotes + cross-asset co-fire scoring with RVTY as the target + the API / MCP feed.Compare tiers →